Found: 42
Select item for more details and to access through your institution.
Genetically modified T cells to target glioblastoma.
- Published in:
- Frontiers in Oncology, 2013, v. 3, p. 1, doi. 10.3389/fonc.2013.00322
- By:
- Publication type:
- Article
IDEAL-IQ in an oncologic population: meeting the challenge of concomitant liver fat and liver iron.
- Published in:
- 2018
- By:
- Publication type:
- journal article
TriDFusion (3DF) image viewer.
- Published in:
- EJNMMI Physics, 2022, v. 9, n. 1, p. 1, doi. 10.1186/s40658-022-00501-y
- By:
- Publication type:
- Article
Combinational Targeting Offsets Antigen Escape and Enhances Effector Functions of Adoptively Transferred T Cells in Glioblastoma.
- Published in:
- Molecular Therapy, 2013, v. 21, n. 11, p. 2087, doi. 10.1038/mt.2013.185
- By:
- Publication type:
- Article
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Solitary Extramedullary Plasmacytoma of the Cricoid Cartilage - Case Report.
- Published in:
- Frontiers in Oncology, 2017, p. 1, doi. 10.3389/fonc.2017.00284
- By:
- Publication type:
- Article
Effects of a Worksite Group Intervention to Promote Physical Activity and Health: The Role of Psychological Coaching.
- Published in:
- Applied Psychology: Health & Well-Being, 2019, v. 11, n. 3, p. 584, doi. 10.1111/aphw.12170
- By:
- Publication type:
- Article
Dosimetric Variability Across a Library of Computational Tumor Phantoms.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 5, p. 782, doi. 10.2967/jnumed.122.264916
- By:
- Publication type:
- Article
Detecting CXCR4 Expression in Meningioma on <sup>68</sup>Ga-Pentixafor PET/MRI.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 4, p. 667, doi. 10.2967/jnumed.122.265127
- By:
- Publication type:
- Article
Interim Analysis of a Prospective Validation of 2 Blood-Based Genomic Assessments (PPQ and NETest) to Determine the Clinical Efficacy of <sup>177</sup>Lu-DOTATATE in Neuroendocrine Tumors.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 4, p. 567, doi. 10.2967/jnumed.122.264363
- By:
- Publication type:
- Article
Patient Size-Dependent Dosimetry Methodology Applied to <sup>18</sup>F-FDG Using New ICRP Mesh Phantoms .
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1255, doi. 10.2967/jnumed.120.256719
- By:
- Publication type:
- Article
Patient Size-Dependent Dosimetry Methodology Applied to <sup>18</sup>F-FDG Using New ICRP Mesh Phantoms.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.256719
- By:
- Publication type:
- Article
Patient Size-Dependent Dosimetry Methodology Applied to 18F-FDG Using New ICRP Mesh Phantoms.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.256719
- By:
- Publication type:
- Article
Patient Size-Dependent Dosimetry Methodology Applied to <sup>18</sup>F-FDG Using New ICRP Mesh Phantoms.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.256719
- By:
- Publication type:
- Article
Patient Size-Dependent Dosimetry Methodology Applied to <sup>18</sup>F-FDG Using New ICRP Mesh Phantoms.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.256719
- By:
- Publication type:
- Article
Patient Size-Dependent Dosimetry Methodology Applied to <sup>18</sup>F-FDG Using New ICRP Mesh Phantoms.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.120.256719
- By:
- Publication type:
- Article
Patient Size-Dependent Dosimetry Methodology Applied to <sup>18</sup>F-FDG Using New ICRP Mesh Phantoms.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.256719
- By:
- Publication type:
- Article
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.234864
- By:
- Publication type:
- Article
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.234864
- By:
- Publication type:
- Article
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.119.234864
- By:
- Publication type:
- Article
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.234864
- By:
- Publication type:
- Article
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 8, p. 1, doi. 10.2967/jnumed.119.234864
- By:
- Publication type:
- Article
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.119.234864
- By:
- Publication type:
- Article
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.119.234864
- By:
- Publication type:
- Article
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.119.234864
- By:
- Publication type:
- Article
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 4, p. 1, doi. 10.2967/jnumed.119.234864
- By:
- Publication type:
- Article
Pharmacokinetic assessment of <sup>18</sup>F-(2S,4R)-4-fluoroglutamine in patients with cancer.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.229740
- By:
- Publication type:
- Article
Imaging of CAR T-cells in cancer patients – paving the way to treatment monitoring and outcome prediction.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.227561
- By:
- Publication type:
- Article
Imaging of CAR T-Cells in Cancer Patients: Paving the Way to Treatment Monitoring and Outcome Prediction.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 7, p. 879, doi. 10.2967/jnumed.119.227561
- By:
- Publication type:
- Article
Antibody with Infinite Affinity for In Vivo Tracking of Genetically Engineered Lymphocytes.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 12, p. 1894, doi. 10.2967/jnumed.118.208041
- By:
- Publication type:
- Article
Comparison of Somatostatin Receptor Agonist and Antagonist for Peptide Receptor Radionuclide Therapy: A Pilot Study.
- Published in:
- Journal of Nuclear Medicine, 2014, v. 55, n. 8, p. 1248, doi. 10.2967/jnumed.114.138834
- By:
- Publication type:
- Article
Immune response after striatal engraftment of fetal neuronal cells in patients with Huntington's disease: Consequences for cerebral transplantation programs.
- Published in:
- Clinical & Experimental Neuroimmunology, 2011, v. 2, n. 2, p. 25, doi. 10.1111/j.1759-1961.2011.00018.x
- By:
- Publication type:
- Article
Identification of incidental brain tumors in prostate cancer patients via PSMA PET/CT.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 163, n. 2, p. 455, doi. 10.1007/s11060-023-04355-x
- By:
- Publication type:
- Article
Correction to: Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 159, n. 3, p. 609, doi. 10.1007/s11060-022-04101-9
- By:
- Publication type:
- Article
Correction to: [<sup>89</sup>Zr]Zr‑huJ591 immuno‑PET targeting PSMA in IDH mutant anaplastic oligodendroglioma.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
[<sup>89</sup>Zr]Zr-huJ591 immuno-PET targeting PSMA in IDH mutant anaplastic oligodendroglioma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 2, p. 783, doi. 10.1007/s00259-021-05543-5
- By:
- Publication type:
- Article
Prognostic value of [<sup>18</sup>F]FDG PET/CT in patients with CNS lymphoma receiving ibrutinib-based therapies.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 12, p. 3940, doi. 10.1007/s00259-021-05386-0
- By:
- Publication type:
- Article
Comparison of 68Ga-DOTA-JR11 PET/CT with dosimetric 177Lu-satoreotide tetraxetan (177Lu-DOTA-JR11) SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapy.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 13, p. 3047, doi. 10.1007/s00259-020-04832-9
- By:
- Publication type:
- Article
Biodistribution and radiation dose estimates for <sup>68</sup>Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumors.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 3, p. 677, doi. 10.1007/s00259-018-4193-y
- By:
- Publication type:
- Article
CAR Chase: Where Do Engineered Cells Go in Humans?
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.577773
- By:
- Publication type:
- Article